FOX BIZ NEWS: Biogen to buy experimental Alzheimer's, Parkinson's treatment from Pfizer for $75M plus incentives

Biogen to buy experimental Alzheimer's, Parkinson's treatment from Pfizer for $75M plus incentives



“This asset is highly complementary to our existing pipeline of potential disease-modifying therapies in Alzheimer’s and Parkinson’s diseases,” Biogen Chief Medical Officer Alfred Sandrock Jr. said in a statement.

via FOX BUSINESS NEWS https://ift.tt/2tZyICr